Perrigo Company plc (NYSE:PRGO – Get Free Report) declared a quarterly dividend on Wednesday, February 19th,RTT News reports. Investors of record on Friday, March 7th will be given a dividend of 0.29 per share on Tuesday, March 25th. This represents a $1.16 dividend on an annualized basis and a yield of 4.68%. This is an increase from Perrigo’s previous quarterly dividend of $0.28.
Perrigo has raised its dividend by an average of 4.8% annually over the last three years and has raised its dividend every year for the last 22 years. Perrigo has a payout ratio of 32.7% meaning its dividend is sufficiently covered by earnings. Research analysts expect Perrigo to earn $3.06 per share next year, which means the company should continue to be able to cover its $1.10 annual dividend with an expected future payout ratio of 35.9%.
Perrigo Stock Up 2.8 %
Perrigo stock traded up $0.67 during mid-day trading on Wednesday, reaching $24.81. The company’s stock had a trading volume of 1,480,463 shares, compared to its average volume of 1,278,541. The company has a market capitalization of $3.38 billion, a price-to-earnings ratio of -21.20 and a beta of 0.54. Perrigo has a 12 month low of $23.14 and a 12 month high of $33.46. The business’s 50 day simple moving average is $25.11 and its 200 day simple moving average is $26.30. The company has a debt-to-equity ratio of 0.94, a quick ratio of 1.77 and a current ratio of 2.56.
Analyst Upgrades and Downgrades
Read Our Latest Stock Analysis on PRGO
Insider Transactions at Perrigo
In other Perrigo news, Director Jeffrey B. Kindler sold 17,598 shares of Perrigo stock in a transaction dated Monday, December 9th. The shares were sold at an average price of $28.27, for a total value of $497,495.46. Following the completion of the sale, the director now owns 5,409 shares in the company, valued at $152,912.43. The trade was a 76.49 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.40% of the stock is currently owned by corporate insiders.
About Perrigo
Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.
See Also
- Five stocks we like better than Perrigo
- When to Sell a Stock for Profit or Loss
- Nebius Group: NVIDIA’s Investment Sparks All-Time Highs
- What is Short Interest? How to Use It
- SoFi Stock Rallying Strong in the Last 5 Days—What’s Driving It?
- The Role Economic Reports Play in a Successful Investment Strategy
- Intel Surges on M&A Talks: Rally Beginning or Just a Headfake?
Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.